NUMANS (02530) Announces Acquisition of XtalPi Shares Valued at HK$19.73 Million

Bulletin Express

03/04

Numans Health Food Holdings Company Limited (NUMANS, 02530) announced an acquisition of 2.00 million shares in XtalPi Holdings Limited on 4 March 2026 for a total of HK$19.73 million. The average purchase price was HK$9.86 per share, and settlement was made in cash from internal resources.

XtalPi adopts quantum physics-based, AI-powered, and robotics-driven research and development, providing solutions and services primarily to global pharmaceutical and material science clients. For the six months ended 30 June 2025, XtalPi’s revenue reached RMB517.08 million, and its profit before taxation was RMB75.61 million.

NUMANS indicated that the acquisition aligns with its strategy to enhance capital efficiency and represents a potential investment opportunity in a leading company in the drug discovery solutions industry. Following previous acquisitions, the listed transaction remains discloseable under relevant regulatory requirements.

免責聲明：投資有風險，本文並非投資建議，以上內容不應被視為任何金融產品的購買或出售要約、建議或邀請，作者或其他用戶的任何相關討論、評論或帖子也不應被視為此類內容。本文僅供一般參考，不考慮您的個人投資目標、財務狀況或需求。TTM對信息的準確性和完整性不承擔任何責任或保證，投資者應自行研究並在投資前尋求專業建議。

熱議股票

{"basename":"/hant","ssrTDKData":{"titleTemplate":"%s - 老虎證券","title":"老虎证券全球投资理财平台| 一站式投资美股新股港股A股","description":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","keywords":"老虎證券,老虎證券開戶,老虎券商,老虎證券官網,老虎證券app,tigertrade老虎證券,股票,炒股,新加坡股票交易平臺,投資,投資理財","social":{"ogDescription":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.0a0bd8dc.png","ogUrl":"https://www.itiger.com/hant/news/1176580709"},"companyName":"老虎證券"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental"},"isCrawlerRequest":true,"__swrFallback__":{"@#url:\"https://stock-news.skytigris.cn/v3/news\",params:#id:\"1176580709\",edition:\"fundamental\",auth_exemption:1,,,undefined,":{"share":"https://ttm.financial/m/news/1176580709?lang=zh_TW&edition=fundamental","thumbnail":"","is_english":true,"pubTime":"2026-03-04 19:22","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"1176580709","market":"hk","top_or_hot":-1,"title":"NUMANS (02530) Announces Acquisition of XtalPi Shares Valued at HK$19.73 Million","media":"Bulletin Express","content":"<p>Numans Health Food Holdings Company Limited (NUMANS, 02530) announced an acquisition of 2.00 million shares in XtalPi Holdings Limited on 4 March 2026 for a total of HK$19.73 million. The average purchase price was HK$9.86 per share, and settlement was made in cash from internal resources.</p>\n<p>XtalPi adopts quantum physics-based, AI-powered, and robotics-driven research and development, providing solutions and services primarily to global pharmaceutical and material science clients. For the six months ended 30 June 2025, XtalPi’s revenue reached RMB517.08 million, and its profit before taxation was RMB75.61 million.</p>\n<p>NUMANS indicated that the acquisition aligns with its strategy to enhance capital efficiency and represents a potential investment opportunity in a leading company in the drug discovery solutions industry. Following previous acquisitions, the listed transaction remains discloseable under relevant regulatory requirements.</p>","source":null,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>NUMANS (02530) Announces Acquisition of XtalPi Shares Valued at HK$19.73 Million</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 12.5px; color: #7E829C; margin: 0;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nNUMANS (02530) Announces Acquisition of XtalPi Shares Valued at HK$19.73 Million\n</h2>\n<h4 class=\"meta\">\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1053168898\">\n\n<div class=\"h-thumb\" style=\"background-image:url(https://community-static.tradeup.com/news/ed558ed0402cbe7d1ef4d150458f2b2e);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Bulletin Express </p>\n<p class=\"h-time smaller\">2026-03-04 19:22</p>\n</div>\n</a>\n</h4>\n</header>\n<article>\n<p>Numans Health Food Holdings Company Limited (NUMANS, 02530) announced an acquisition of 2.00 million shares in XtalPi Holdings Limited on 4 March 2026 for a total of HK$19.73 million. The average purchase price was HK$9.86 per share, and settlement was made in cash from internal resources.</p>\n<p>XtalPi adopts quantum physics-based, AI-powered, and robotics-driven research and development, providing solutions and services primarily to global pharmaceutical and material science clients. For the six months ended 30 June 2025, XtalPi’s revenue reached RMB517.08 million, and its profit before taxation was RMB75.61 million.</p>\n<p>NUMANS indicated that the acquisition aligns with its strategy to enhance capital efficiency and represents a potential investment opportunity in a leading company in the drug discovery solutions industry. Following previous acquisitions, the listed transaction remains discloseable under relevant regulatory requirements.</p>\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"02530","symbol_name":"紐曼思","start_time":0,"source_url":"","article_id":"1176580709","we_media_id":"1053168898","thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=1176580709","pubTimestamp":1772623337,"columns":[],"sourceInfo":null,"weMediaInfo":{"media_name":"Bulletin Express","introduction":"Full Coverage of HK & US Stock Announcements","home_visible":1,"id":"1053168898","head_image":"https://community-static.tradeup.com/news/ed558ed0402cbe7d1ef4d150458f2b2e"},"summary":"Numans Health Food Holdings Company Limited (NUMANS, 02530) announced an acquisition of 2.00 million shares in XtalPi Holdings Limited on 4 March 2026 for a total of HK$19.73 million. The average...","collect":0,"end_time":0,"defaultTopTitle":"","property":[],"viewcount":null,"language":"en","relate_stocks":{"02530":"纽曼思"},"translate_title":"纽曼斯(02530)宣布收购价值1973万港元XtalPi股份","themeId":null,"isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"02530":1},"content_text":"Numans Health Food Holdings Company Limited (NUMANS, 02530) announced an acquisition of 2.00 million shares in XtalPi Holdings Limited on 4 March 2026 for a total of HK$19.73 million. The average purchase price was HK$9.86 per share, and settlement was made in cash from internal resources.\nXtalPi adopts quantum physics-based, AI-powered, and robotics-driven research and development, providing solutions and services primarily to global pharmaceutical and material science clients. For the six months ended 30 June 2025, XtalPi’s revenue reached RMB517.08 million, and its profit before taxation was RMB75.61 million.\nNUMANS indicated that the acquisition aligns with its strategy to enhance capital efficiency and represents a potential investment opportunity in a leading company in the drug discovery solutions industry. Following previous acquisitions, the listed transaction remains discloseable under relevant regulatory requirements.","kind":"news","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":true,"editions":null,"column":"","sentiment":"1","news_tag":"corporation,SGX","news_rank":0,"isVideo":false,"video":null,"symbols":[],"gpt_button":0,"need_auth":false,"need_login_tip":false,"code":"91000000","status":"200"}}}